文献速递细菌感染、耐药与抗菌药物医院感染防控

对拟议的复杂性凝固酶阴性葡萄球菌菌血症定义的验证

Validation of the Proposed Definition for Complicated Coagulase-negative Staphylococcal Bacteremia.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该回顾性研究在瑞士洛桑大学医院纳入2015至2023年326例成人凝固酶阴性葡萄球菌菌血症,评估拟议的复杂性菌血症定义并分析死亡预测因素;复杂性菌血症30天死亡率与不复杂性无差异,感染科48小时内会诊和48小时内感染源控制与改善结局相关。

要点

  • 拟议的复杂性凝固酶阴性葡萄球菌菌血症定义未能识别30天死亡风险更高的患者。
  • 感染科48小时内会诊与30天死亡率降低相关(调整HR 0.22)。
  • 48小时内感染源控制与30天死亡率降低相关(调整HR 0.12)。

核心结论

  • 拟议的复杂性凝固酶阴性葡萄球菌菌血症定义在本队列中未能识别死亡风险更高的患者。
  • 研究结果强调感染科会诊在指导抗菌治疗和推荐感染源控制干预中的重要性。

研究设计与样本

  • 回顾性研究,在瑞士洛桑大学医院开展,纳入2015至2023年成人凝固酶阴性葡萄球菌菌血症患者。

主要发现

  • 研究期间共纳入326例凝固酶阴性葡萄球菌菌血症,其中250例(77%)涉及表皮葡萄球菌。
  • 大多数感染为导管相关菌血症(233例;68%)。
  • 根据拟议定义,195例(60%)为复杂性感染。
  • 总体30天死亡率为9%(29例)。
  • 复杂性感染与不复杂性感染的30天死亡率无差异(10% vs 7%;P = .327)。

关键数值与推荐

  • 复杂性感染30天死亡率10% vs 不复杂性感染7%(P = .327)。
  • Charlson合并症指数>4的调整风险比3.80(95%置信区间1.52-9.47)。
  • 48小时内感染科会诊的调整风险比0.22(95%置信区间0.10-0.48)。
  • 48小时内感染源控制干预的调整风险比0.12(95%置信区间0.03-0.50)。
  • 复杂性感染的调整风险比0.39(95%置信区间0.10-1.46)。

临床怎么用

  • 感染科会诊在285/326例(87%)中于菌血症起病48小时内提供。
  • 感染源控制被认为必要的有275例(84%),其中167/275例(61%)在48小时内实施。
  • 作者认为研究结果强调感染科会诊在指导抗菌治疗和推荐感染源控制干预中的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A new definition for complicated coagulase-negative staphylococcal (CoNS) bacteremia was recently proposed. The aim of this study was to identify predictors of mortality in patients with CoNS bacteremia and evaluate the proposed definition of complicated bacteremia. METHODS: This retrospective study was conducted at the Lausanne University Hospital, Switzerland (2015-2023) and included adult patients with CoNS bacteremia. RESULTS: During the study period, 326 episodes of CoNS bacteremia were included, with 250 (77%) episodes involving Staphylococcus epidermidis. Most infections were catheter-related bacteremias (233 episodes; 68%). Based on the proposed definition, 195 (60%) episodes had complicated disease. The overall 30-day mortality was 9% (29 episodes). Infectious diseases (ID) consultation was provided within 48 hours from bacteremia onset in 285/326 (87%) episodes. Source control was deemed necessary in 275 (84%) episodes and was performed within 48 hours in 167/275 (61%) episodes. No difference on 30-day mortality was observed among complicated and uncomplicated disease (10% vs 7%; P = .327). The Cox multivariable regression model showed that a Charlson comorbidity index >4 (adjusted hazard ratio, 3.80; 95% confidence interval, 1.52-9.47) was associated with 30-day mortality, whereas ID consultation within 48 hours (0.22, 0.10-0.48) and performance of source control interventions within 48 hours (0.12, 0.03-0.50) were associated with improved outcome. Complicated disease was not associated with 30-day mortality (0.39, 0.10-1.46). CONCLUSIONS: The proposed definition for complicated CoNS bacteremia failed to identify patients at higher risk for mortality in our cohort. Our findings highlight the importance of ID consultation in guiding antimicrobial treatment and recommending source control interventions for patients with CoNS bacteremia.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Papadimitriou-Olivgeris M, Senn L, Guery B, et al. Validation of the Proposed Definition for Complicated Coagulase-negative Staphylococcal Bacteremia. Clin Infect Dis. 2025. PMID: 40077942. doi:10.1093/cid/ciaf119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。